Literature DB >> 18511209

The shell of the nucleus accumbens has a higher dopamine response compared with the core after non-contingent intravenous ethanol administration.

E C Howard1, C J Schier, J S Wetzel, C L Duvauchelle, R A Gonzales.   

Abstract

Dopamine increases in the nucleus accumbens after ethanol administration in rats, but the contributions of the core and shell subregions to this response are unclear. The goal of this study was to determine the effect of various doses of i.v. ethanol infusions on dopamine in these two subregions of the nucleus accumbens. Male Long-Evans rats were infused with either acute i.v. ethanol (0.5, 1.0, 1.5 g/kg), repeated i.v. ethanol (four 1.0 g/kg infusions resulting in a cumulative dose of 4.0 g/kg), or saline as a control for each condition. Dopamine and ethanol were measured in dialysate samples from each experiment. The in vivo extraction fraction for ethanol of probes was determined using i.v. 4-methylpyrazole, and was used to estimate peak brain ethanol concentrations after the infusions. The peak brain ethanol concentrations after the 0.5, 1.0 and 1.5 g/kg ethanol infusions were estimated to be 20, 49 and 57 mM, respectively. A significant dopamine increase was observed for the 0.5 g/kg ethanol group when collapsed across subregions. However, both the 1.0 g/kg and 1.5 g/kg ethanol infusions produced significant increases in dopamine levels in the shell that were significantly higher than those in the core. An ethanol dose-response effect on dopamine in the shell was observed when saline controls, 0.5, 1.0, and 1.5 g/kg groups were compared. For the cumulative-dosing study, the first, second, and fourth infusions resulted in significant increases in dopamine in the shell. However, these responses were not significantly different from one another. The results of this study show that the shell has a stronger response than the core to i.v. ethanol, that dopamine in the shell increases in a dose-dependent manner between 0.5-1.0 g/kg doses, but that the response to higher ethanol doses reaches a plateau.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18511209      PMCID: PMC2904606          DOI: 10.1016/j.neuroscience.2008.04.014

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  64 in total

Review 1.  The dopamine hypothesis of reward: past and current status.

Authors:  R Spanagel; F Weiss
Journal:  Trends Neurosci       Date:  1999-11       Impact factor: 13.837

2.  The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent.

Authors:  M Barrot; M Marinelli; D N Abrous; F Rougé-Pont; M Le Moal; P V Piazza
Journal:  Eur J Neurosci       Date:  2000-03       Impact factor: 3.386

3.  Microdialysis of dopamine in the nucleus accumbens of alcohol-preferring (P) rats during anticipation and operant self-administration of ethanol.

Authors:  Roberto I Melendez; Zachary A Rodd-Henricks; Eric A Engleman; Ting-Kai Li; William J McBride; James M Murphy
Journal:  Alcohol Clin Exp Res       Date:  2002-03       Impact factor: 3.455

4.  Effect of gender and estrous cycle on the pharmacokinetics of ethanol in the rat brain.

Authors:  Donita L Robinson; Lane J Brunner; Rueben A Gonzales
Journal:  Alcohol Clin Exp Res       Date:  2002-02       Impact factor: 3.455

5.  Differential adaptive properties of accumbens shell dopamine responses to ethanol as a drug and as a motivational stimulus.

Authors:  Valentina Bassareo; Maria Antonietta De Luca; Marzia Aresu; Alessandra Aste; Teresa Ariu; Gaetano Di Chiara
Journal:  Eur J Neurosci       Date:  2003-04       Impact factor: 3.386

Review 6.  Behavioral neurobiology of alcohol addiction: recent advances and challenges.

Authors:  Friedbert Weiss; Linda J Porrino
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

7.  Dopamine responsiveness to drugs of abuse: A shell-core investigation in the nucleus accumbens of the mouse.

Authors:  Alessandro Zocchi; Elena Girlanda; Giorgia Varnier; Ilaria Sartori; Lara Zanetti; Grant A Wildish; Mark Lennon; Manolo Mugnaini; Christian A Heidbreder
Journal:  Synapse       Date:  2003-12-15       Impact factor: 2.562

8.  Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants.

Authors:  F Weiss; M T Lorang; F E Bloom; G F Koob
Journal:  J Pharmacol Exp Ther       Date:  1993-10       Impact factor: 4.030

9.  Ethanol increases extracellular dopamine concentration in the ventral striatum in C57BL/6 mice.

Authors:  Amanda Tang; Magnia A George; Judith A Randall; Rueben A Gonzales
Journal:  Alcohol Clin Exp Res       Date:  2003-07       Impact factor: 3.455

10.  Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens.

Authors:  R A Gonzales; F Weiss
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

View more
  35 in total

1.  GABAergic transmission modulates ethanol excitation of ventral tegmental area dopamine neurons.

Authors:  J W Theile; H Morikawa; R A Gonzales; R A Morrisett
Journal:  Neuroscience       Date:  2010-10-23       Impact factor: 3.590

2.  Sex differences in striatal dopamine release in young adults after oral alcohol challenge: a positron emission tomography imaging study with [¹¹C]raclopride.

Authors:  Nina B L Urban; Lawrence S Kegeles; Mark Slifstein; Xiaoyan Xu; Diana Martinez; Ehab Sakr; Felipe Castillo; Tiffany Moadel; Stephanie S O'Malley; John H Krystal; Anissa Abi-Dargham
Journal:  Biol Psychiatry       Date:  2010-08-03       Impact factor: 13.382

3.  General anesthetic exposure in adolescent rats causes persistent maladaptations in cognitive and affective behaviors and neuroplasticity.

Authors:  Justine D Landin; Magdalena Palac; Jenna M Carter; Yvette Dzumaga; Jessica L Santerre-Anderson; Gina M Fernandez; Lisa M Savage; Elena I Varlinskaya; Linda P Spear; Scott D Moore; H Scott Swartzwelder; Rebekah L Fleming; David F Werner
Journal:  Neuropharmacology       Date:  2019-03-26       Impact factor: 5.250

4.  Microdialysis of ethanol during operant ethanol self-administration and ethanol determination by gas chromatography.

Authors:  Christina J Schier; Regina A Mangieri; Geoffrey A Dilly; Rueben A Gonzales
Journal:  J Vis Exp       Date:  2012-09-05       Impact factor: 1.355

5.  Quantitative unit classification of ventral tegmental area neurons in vivo.

Authors:  Wei Li; William M Doyon; John A Dani
Journal:  J Neurophysiol       Date:  2012-02-29       Impact factor: 2.714

6.  Role of nucleus accumbens μ opioid receptors in the effects of morphine on ERK1/2 phosphorylation.

Authors:  Michela Rosas; Simona Porru; Sandro Fenu; Stefania Ruiu; Alessandra T Peana; Alessandro Papale; Riccardo Brambilla; Gaetano Di Chiara; Elio Acquas
Journal:  Psychopharmacology (Berl)       Date:  2016-05-31       Impact factor: 4.530

7.  General Anesthetic Exposure During Early Adolescence Persistently Alters Ethanol Responses.

Authors:  Justine D Landin; Jonathan K Gore-Langton; Elena I Varlinskaya; Linda P Spear; David F Werner
Journal:  Alcohol Clin Exp Res       Date:  2020-02-18       Impact factor: 3.455

8.  Intravenous ethanol increases extracellular dopamine in the medial prefrontal cortex of the Long-Evans rat.

Authors:  Christina J Schier; Geoffrey A Dilly; Rueben A Gonzales
Journal:  Alcohol Clin Exp Res       Date:  2013-02-19       Impact factor: 3.455

9.  Ethanol is self-administered into the nucleus accumbens shell, but not the core: evidence of genetic sensitivity.

Authors:  Eric A Engleman; Zheng-Ming Ding; Scott M Oster; Jamie E Toalston; Richard L Bell; James M Murphy; William J McBride; Zachary A Rodd
Journal:  Alcohol Clin Exp Res       Date:  2009-09-17       Impact factor: 3.455

10.  Disparity between tonic and phasic ethanol-induced dopamine increases in the nucleus accumbens of rats.

Authors:  Donita L Robinson; Elaina C Howard; Scott McConnell; Rueben A Gonzales; R Mark Wightman
Journal:  Alcohol Clin Exp Res       Date:  2009-04-09       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.